4.7 Article

IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling

Journal

SCIENTIFIC REPORTS
Volume 9, Issue -, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-019-44048-y

Keywords

-

Funding

  1. National Natural Science Foundation of China [81572393, 81602093, 81602054]
  2. Nanjing Municipality Health Bureau [ZKX15020, ZKX17022]
  3. Natural Science Foundation of Jiangsu Province [BK20151042, BK20160118]
  4. National Basic Research Program of China (973 Program) [2013CB834100]
  5. Primary Research & Developement Plan of Jiangsu Province [BE2018701]
  6. Young Talents Hausen Fund of Lianyungang Clinical College of Nanjing Medical University [QN150102]
  7. Foundation of Health and Family planning Commission of Lianyungang [201802]
  8. Fundamental Research Funds for the Central Universities [021414380215, 021414380329, 020414380080]
  9. Medical Science and Technology Development Foundation

Ask authors/readers for more resources

IQ motif-containing GTPase-activating protein 1 (IQGAP1) is a scaffold protein that participates in several cellular functions, including cytoskeletal regulation, cell adhesion, gene transcription and cell polarization. IQGAP1 has been implicated in the tumorigenesis and progression of several human cancers. However, the role of IQGAP1 in pancreatic ductal adenocarcinoma (PDAC) is still unknown. We found that IQGAP1 expression was an independent prognostic factor for PDAC. IQGAP1 upregulation significantly promoted cell proliferation, migration, invasion and epithelial-mesenchyma I transition (EMT), whereas IQGAP1 downregulation impaired its oncogenic functions. Overexpression of IQGAP1 increased the protein level of Dishevelled2 (DVL2) and enhanced canonical Wnt signaling as evidenced by increased DVL2 level, beta-catenin transcriptional activity, beta-catenin nuclear translocation and expression of the direct target genes of beta-catenin (cyclin D1 and c-myc). In contrast, knockdown of IQGAP1 decreased the level of DVL2 and attenuated Wnt/beta-catenin signaling. In vivo results revealed that IQGAP1 promoted tumor growth and metastasis. Co-immunoprecipitation studies demonstrated that IQGAP1 interacted with both DVL2 and beta-catenin. Moreover, knockdown of DVL2 reversed IQGAP1-induced EMT. Our findings thus confirmed that IQGAP1 could be used as a potential target for PDAC treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available